News

The new data showed that a single injection of ocriplasmin resolved VMA and the visual symptoms associated with it in 29.8% of VMT patients, compared with 7.7% of

Sansoz has filed the case with a hope that the court will find that its generic version of Novo Nordisk’s diabetes drug Prandin (repaglinide) is non-infringing, Bloomberg reported.

Tolnaftate, the active ingredient of Tolnaftate-D, is already approved as a treatment of jock itch, athlete’s foot and ringworm. Apricus Biosciences wholly owned subsidiary NexMed’s Tolnaftate-D uses NexACT

Previously, Valeant signed a deal to take over Lithuania-based specialty pharmaceuticals company AB Sanitas for around EUR314m. Sanitas has a range of branded generics product portfolio consisting of

The drug has been approved for the patients with Hodgkin lymphoma and for the patients suffering from systemic anaplastic large cell lymphoma (ALCL). The approvals were given on

With this acquisition, Atrium will take over a manufacturing plant and process that is approved by different regulatory bodies in countries where Wobenzym products are sold. Atrium distributes

The projects – aimed at treating conditions such as vision loss, neurodegenerative disease and depression – are funded through the NIH Blueprint for Neuroscience Research. The NIH Blueprint

Furiex will use the loan to support research and development for clinical stage compounds JNJ-Q2, MuDelta and PPD10558. Furiex Pharmaceuticals chief financial officer, treasurer and assistant secretary Marshall

The company informed that at a median of 17 months follow-up, the relapse rate in patients with low levels of HER2 expression treated with AE37 is half that